Genetic regulation of bone mass: from bone density to bone strength.
Osteoporosis is a common disease characterized in adults by diminished bone density. Bone is an organ that evolves and grows throughout life, and establishing optimal bone density in childhood and adolescence serves to buffer bone loss later in life. Bone density, a measurable entity, is the clinical substitute for bone strength, or the ability to defend against fracture. Chronic diseases may adversely affect optimal peak bone density. Bone density is under genetic control, as revealed by three lines of investigations. These include (1) the finding of quantitative trait loci for bone density, (2) the finding that specific mutations in genes that are important in the development of osteoblast or osteoclast lineages alter bone density, and (3) the linkeage of known polymorphisms for genes involved in mineral homeostasis to bone density and/or fracture. Future therapeutics for improving peak bone density or delaying bone loss later in life may take advantage of the genetic nature of bone density development.
Langman
Craig B
CB
Division of Kidney Diseases, Children's Memorial Hospital, 2300 Children's Plaza, MS 37, Chicago, IL 60614, USA. c-langman@northwestern.edu
D015519:Bone Density / Q000235:genetics*; D001842:Bone and Bones / Q000502:physiology*; D002648:Child; D005786:Gene Expression Regulation; D006801:Humans; D010006:Osteoblasts; D010024:Osteoporosis / Q000235:genetics / Q000503:physiopathology; D040641:Quantitative Trait Loci